Corporate Action26 Oct 2026, 01:30 pm
Chandra Bhagat Pharma: Promoter Group Acquires Warrants
AI Summary
Chandra Bhagat Pharma Ltd has disclosed a significant transaction involving its promoter and promoter group. Hemant Chandravadan Bhagat and Persons Acting in Concert (PACs) were allotted 50,00,000 convertible warrants on October 22, 2026, via a preferential issue. This allotment increases the promoter group's total holding to 74.29% of the total diluted share capital, up from 70.09% before the transaction. The total diluted share capital post-allotment is 1,41,45,056 equity shares.
Key Highlights
- Promoter group acquired 50,00,000 convertible warrants via preferential issue.
- Total holding of promoter group increased to 74.29% post-allotment.
- Transaction represents an increase of 4.20% in promoter group's shareholding.
- Warrants are convertible into equity shares, impacting diluted capital.
Price Impact
More from CBPL